e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.4135 +0.0419 (+11.28%)

Streaming Delayed Price Updated: 9:50 AM EDT, Apr 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

April 26, 2022

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

Via Benzinga

Gossamer Bio Pulls Plug On Mid-Stage Ulcerative Colitis Program ↗

April 25, 2022

Via Benzinga

Recap: Gossamer Bio Q4 Earnings ↗

March 03, 2022

Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Gossamer Bio Earnings Preview ↗

March 02, 2022

Gossamer Bio (NASDAQ:GOSS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

Gossamer Bio Announces GB004 Topline Results from Phase 2 SHIFT-UC Study in Ulcerative Colitis and Provides Corporate Update

April 25, 2022

From Gossamer Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022 ↗

April 18, 2022

Upgrades

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 06, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

Gossamer Bio to Announce Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call and Webcast on March 3, 2022

February 28, 2022

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update

November 08, 2021

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021

November 02, 2021

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208

October 11, 2021

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021

October 07, 2021

From Gossamer Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 27, 2021

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...

Via Benzinga

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive ↗

September 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...

Via Benzinga

31 Stocks Moving In Monday's Mid-Day Session ↗

September 27, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 54.1% to $3.6998 after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from NASA to...

Via Benzinga

50 Biggest Movers From Yesterday ↗

September 28, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 50% to close at $3.60 on Monday after the company said its subsidiary, Skypersonic, Inc, won a five-year contract from...

Via Benzinga

Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role

September 21, 2021

From Gossamer Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 20, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 16, 2021

Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company...

Via Benzinga

Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 09, 2021

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021

August 02, 2021

From Gossamer Bio, Inc.

Via Business Wire

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation

July 07, 2021

From Gossamer Bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy